- Home
- / Haystack Oncology
Haystack Oncology
Total Funding
$56 M
Haystack Oncology Summary
Company Summary
- Overview
- Haystack Oncology is a company specializing in liquid biopsy solutions for the biopharma industry. It offers circulating tumor DNA (ctDNA) and minimal residual disease (MRD) testing that enable the detection of residual tumor DNA . The company also provides treatment plans.
- Type
- Private
- Status
- Active
- Founded
- 2021
- HQ
- Baltimore, MD, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Frank Holtrup, Chief Technology Officer
Joshua Cohen, Chief Innovation Officer and Co-Founder
Joel Kaufman, Chief Financial Officer
Operating MetricsView all
Advisors
11
Apr, 2023
LocationsView all
2 locations detected
Baltimore, MD HQ
United States
301 W 29th St
Hamburg, HH
Germany
Luruper Hauptstraße 1